# Marker Therapeutics, Inc.: Form 8-K, filed Feb 26, 2024

- Company: [Marker Therapeutics, Inc.](/companies/mrkr.md) (CIK 1094038)
- Form: 8-K
- Filed: 2024-02-26
- Accepted by EDGAR: Feb 26, 2024, 12:58 ET
- Period: 2024-02-22
- Accession: 0001104659-24-027293
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1094038/000110465924027293/tm247177d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1094038/000110465924027293/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1094038/000110465924027293/tm247177d1_8k.htm

Filed Feb 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-027293. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.